Read more information about Lareb and our research about adverse drugs reactions (ADRs)
Home
Actueel
-
14 november 2024COVID-19 vaccination during pregnancy and neonatal health
Using data from the Dutch Pregnancy Drug Register, Netherlands Pharmacovigilance Centre Lareb found no association between COVID-19 vaccination during pregnancy and the neonatal health outcomes small ...
-
13 november 2024Nerve damage due to the use of nutritional supplements with vitamin B6
The Netherlands Pharmacovigilance Centre Lareb has previously reported on nerve damage caused by the use of nutritional supplements containing vitamin B6. These reports are still being received by Lar...
-
04 november 2024MedSafetyWeek 2024
Today, the MedSafetyWeek starts. The MedSafetyWeek is an annual (social) media campaign focussing on raising awareness of pharmacovigilance, and promoting recognition and reporting of suspected advers...
View reports
Enter at least the first four letters of the name of the medicine you are looking for in the first search bar. Then choose the right medicine.
If applicable, then select the correct dosage form in the second bar, such as: effervescent tablet, chewable tablet, suppository or oral solution.
What does Lareb do
-
News
Lareb shares information about adverse drug reactions (ADR’s) and other news about safe use of medicines. View all news items on our news items page. -
Teratology Information Service
The Teratology Information Service (TIS) is the knowledge centre of Lareb on safety of drugs used before and during pregnancy and during breastfeeding -
Research activities of Lareb
We continuously conduct research with questionnaires. This way, we learn more about known ADR's of medicines and vaccines and we learn to recognize these earlier.